Source:http://linkedlifedata.com/resource/pubmed/id/20670178
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2010-11-24
|
| pubmed:abstractText |
Actinic keratoses (AK) represent a worldwide problem with continuously increasing incidence. AK are characterized by a proliferation of atypical keratinocytes limited to the epidermis, but they may develop into invasive squamous cell carcinoma. In this regard, novel treatment modalities have been developed that allow treatment of the whole actinically damaged field.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1744-7623
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
15
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
545-55
|
| pubmed:meshHeading |
pubmed-meshheading:20670178-Administration, Cutaneous,
pubmed-meshheading:20670178-Carcinoma, Squamous Cell,
pubmed-meshheading:20670178-Cell Proliferation,
pubmed-meshheading:20670178-Drug Design,
pubmed-meshheading:20670178-Humans,
pubmed-meshheading:20670178-Keratosis, Actinic,
pubmed-meshheading:20670178-Photochemotherapy,
pubmed-meshheading:20670178-Skin Neoplasms
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Emerging drugs for actinic keratosis.
|
| pubmed:affiliation |
Charité Universitätsmedizin Berlin, Skin Cancer Centre, Department of Dermatology, Charitéplatz 1, D-10117 Berlin, Germany. martina.ulrich@charite.de
|
| pubmed:publicationType |
Journal Article,
Review
|